Skip to content

When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

PLOS BLOGS Speaking of Medicine and Health

Daily Click: GSK response on the “Right to Health”

In a recent response to a report prepared by Paul Hunt, former UN Special Rapporteur, the pharmaceutical company GlaxoSmithKline (GSK) has argued that the responsibilities of pharmaceutical companies with respect to the “right to health” is not clearly defined. GSK further comments that its current initiatives, such research and development programmes which target diseases of the developing world, and preferential pricing for low-income countries, do not constitute commitments required by international legal norms. GSK’s response is accessible here. Paul Hunt’s report can be downloaded at

Leave a Reply

Your email address will not be published. Required fields are marked *

Add your ORCID here. (e.g. 0000-0002-7299-680X)

Back to top